Pharmacoeconomic issues in clinical care of patients with UTIs.
D000892:Anti-Infective Agents, Urinary / Q000191:economics* / Q000627:therapeutic use; D024901:Drug Resistance, Multiple, Bacterial / Q000187:drug effects*; D017850:Economics, Pharmaceutical; D004926:Escherichia coli / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000191:economics* / Q000453:epidemiology; D006801:Humans; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000191:economics* / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000191:economics* / Q000453:epidemiology
D000892:Anti-Infective Agents, Urinary; D015662:Trimethoprim, Sulfamethoxazole Drug Combination